Results 241 to 250 of about 361,535 (269)

Beyond the Genome: Can Epigenetics Forecast Therapeutic Success in Graves' Disease and Thyroid Eye Disease? [PDF]

Int J Mol Sci
Manso J, Sardone D, Marotta V, Salcuni AS, Brunetti A, Cipri C, Sciannimanico SM, Piva L, Carpentieri M, Falchetti A, Vescini F.   +10 more
europepmc   +1 more source

The Utilization of Silica–Lignin Composite as a Green Adsorbent for Cobalt and Lead Metal Ions in Aqueous Phase

Asia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Heavy metals in environmental waste can pollute the environment and disrupt human health if not managed properly. Heavy metal contamination from industrial waste, particularly cobalt (Co) and lead (Pb), poses serious environmental and health risks due to their toxicity, persistence, and bioaccumulative nature.
Rista Siti Mawarni, Gabrielo Ryan Antoro, Ayu Dahliyanti, Witta Kartika Restu   +3 more
wiley   +1 more source

Myasthenia gravis complicated by Graves' disease: a case report. [PDF]

J Med Case Rep
Kamabu LK, Oboth R, Kataka LM, Baruani AY, Lekuya HM, Kangitsi CK.   +5 more
europepmc   +1 more source

Subglottic Stenosis After Radioactive Iodine Treatment for Graves' Disease: A Case Report. [PDF]

Head Neck
Ettlin C, Giger R, Jaquet Y, Tschopp S.
europepmc   +1 more source

Coexisting Graves' Disease and Papillary Thyroid Carcinoma: The Importance of Nodule Surveillance in Autoimmune Hyperthyroidism. [PDF]

Cureus
Leon Figueredo E, Cuni Hernandez AB, Vega Fuentes A, Vargas Rivera JT, Oropesa E, Silvera R.   +5 more
europepmc   +1 more source

Pediatric Graves' disease: insights into clinical characteristics and treatment outcomes. [PDF]

Arch Endocrinol Metab
Anand A, Nagarajappa VH, Palany R.
europepmc   +1 more source

Predictive factors for the efficacy of radioiodine therapy in patients with Graves' disease. [PDF]

Nucl Med Commun
Iwanaga H, Fujita N, Abe S, Ito R, Abe Y, Minamimoto R, Nishii R, Naganawa S, Kato K.   +8 more
europepmc   +1 more source

Correction to: "Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease".

J Clin Endocrinol Metab
europepmc   +1 more source

Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease.

J Clin Endocrinol Metab
Miyamura K, Ito M, Yamaoka H, Hisakado M, Nishihara E, Fukata S, Nishikawa M, Miyauchi A, Akamizu T.   +8 more
europepmc   +1 more source